Ultrasound-Guided Biopsy for Breast Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to compare the effectiveness of an ultrasound-guided biopsy in detecting signs of breast cancer to findings from surgery. The technique focuses on gathering information about the cancer before surgery. It may suit patients diagnosed with triple-negative or HER2 amplified breast cancer who are scheduled for preoperative treatment and surgery. As an unphased trial, it offers patients the chance to contribute to research that could enhance diagnostic techniques before surgery.
Will I have to stop taking my current medications?
The trial protocol does not specify whether you need to stop taking your current medications.
What prior data suggests that this ultrasound-guided biopsy is safe for breast cancer patients?
Research has shown that ultrasound-guided biopsies are safe and generally well-tolerated. One study involving 677 patients who underwent ultrasound-guided breast biopsies reported no major problems, indicating the procedure's usual safety. Another study found that using a larger needle for the biopsy was also safe and effective for examining tissue.
A review of multiple studies found that ultrasound-guided biopsies accurately detect breast cancer. Complications are rare and usually minor, such as small bruises. Overall, this evidence suggests that ultrasound-guided biopsy is a safe choice for those considering participation in a clinical trial.12345Why are researchers excited about this trial?
Researchers are excited about the ultrasound-guided biopsy technique for breast cancer because it allows for precise targeting of the tumor site, potentially leading to more accurate diagnosis compared to traditional methods like mammography or MRI-guided biopsies. This method uses real-time imaging, which helps in avoiding unnecessary tissue removal and can be less invasive. Additionally, it can be performed more quickly and conveniently, potentially reducing patient discomfort and anxiety associated with longer procedures.
What evidence suggests that an ultrasound-guided biopsy is effective for detecting breast cancer?
Studies have shown that ultrasound-guided biopsies are highly effective for detecting breast cancer. Research indicates that this method correctly identifies cancer 98% of the time and rarely produces false positives. One study demonstrated that this approach can help avoid surgery in about 85% of cases, offering a less invasive option. Specifically, patients who underwent ultrasound-guided biopsies had a 97.2% rate of being cancer-free after three years. These findings suggest that ultrasound-guided biopsies provide a reliable and efficient way to diagnose breast cancer.34567
Who Is on the Research Team?
Henry M. Kuerer
Principal Investigator
M.D. Anderson Cancer Center
Are You a Good Fit for This Trial?
This trial is for adults over 18 with a specific type of breast cancer (either triple negative or HER2 amplified) at various stages. Participants are those who have received preoperative therapy and are planning to undergo surgery.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Biopsy
Participants undergo an ultrasound-guided biopsy of the tumor site to collect cells and tissue samples
Surgery and Post-operative Care
Participants have the planned surgery and receive post-operative care
Follow-up
Participants are monitored for general health and surgery outcomes through routine follow-up visits
What Are the Treatments Tested in This Trial?
Interventions
- Ultrasound-Guided Biopsy
Find a Clinic Near You
Who Is Running the Clinical Trial?
M.D. Anderson Cancer Center
Lead Sponsor